Olympus Announces Co-Development Agreement with AI4GI

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced its co-development agreement with AI4GI, a commercial joint venture between Satis Operations and Imagia. Their Artificial Intelligence (AI) solution for real-time clinical decision support during screening and surveillance colonoscopy procedures will be exclusively offered by Olympus America Inc. (OAI). This co-development agreement is intended to raise the bar for all physicians to ultimately improve clinical outcomes, reduce overall costs and enhance the quality of life for patients. 

Related posts

Genomics at Imagia :                                  How AI can help unlock the clinical power of genomic data

Genomics at Imagia : How AI can help unlock the clinical power of genomic data

Genomic data has the potential to be clinically useful, but its use today is very limited – this potential has not been realized. Imag

...
Read more
Imagia Announces the Appointment of Jennifer M. Buechel to its Board of Directors

Imagia Announces the Appointment of Jennifer M. Buechel to its Board of Directors

Imagia boosts its Board of Directors with an experienced biotech industry leader with strong dual domain expertise in technology and healthc

...
Read more
Conditional Generation of Medical Images via Disentangled Adversarial Inference

Conditional Generation of Medical Images via Disentangled Adversarial Inference

Mohammad Havaei, Ximeng Mao, Yiping Wang, Qicheng Lao. Medical Image Analysis, 2021, 102106, ISSN 1361-8415.


...
Read more